APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endometriosis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endometriosis Treatment Drugs Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchEndometriosis Treatment Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Endometriosis Treatment Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Endometriosis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endometriosis Treatment Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Endometriosis Treatment Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Endometriosis Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endometriosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endometriosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endometriosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endometriosis Treatment Drugs include Debiopharm Group, Endoceutics, Inc, Mayne Pharma Group, Myovant Sciences Ltd, AstraZeneca, AbbVie Inc, Bayer AG, Pfizer Inc and Teva Pharmaceutical Industries Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endometriosis Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endometriosis Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endometriosis Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endometriosis Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endometriosis Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endometriosis Treatment Drugs Market by Company

Debiopharm Group

Endoceutics, Inc

Mayne Pharma Group

Myovant Sciences Ltd

AstraZeneca

AbbVie Inc

Bayer AG

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Ipsen Pharma

Endometriosis Treatment Drugs Segment by Type

Oral Type

Others

Endometriosis Treatment Drugs Segment by Application

Hospital Pharmacies

E-Commerce

Retail Pharmacies

Others

Endometriosis Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endometriosis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endometriosis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endometriosis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endometriosis Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endometriosis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Type Table 2. Major Company of Others Table 3. Global Endometriosis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Endometriosis Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Endometriosis Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Endometriosis Treatment Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Endometriosis Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Endometriosis Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Endometriosis Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Endometriosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Endometriosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Endometriosis Treatment Drugs Industry Trends Table 25. Endometriosis Treatment Drugs Industry Drivers Table 26. Endometriosis Treatment Drugs Industry Opportunities and Challenges Table 27. Endometriosis Treatment Drugs Industry Restraints Table 28. Global Endometriosis Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Endometriosis Treatment Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Endometriosis Treatment Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Endometriosis Treatment Drugs Sales Share by Company (2021-2026) Table 32. Global Endometriosis Treatment Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Endometriosis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Endometriosis Treatment Drugs Major Company Production Sites and Headquarters Table 35. Global Endometriosis Treatment Drugs Company, Product Type & Application Table 36. Global Endometriosis Treatment Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Endometriosis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Endometriosis Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Endometriosis Treatment Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Endometriosis Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Endometriosis Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Endometriosis Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Endometriosis Treatment Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Endometriosis Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Endometriosis Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Endometriosis Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Endometriosis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Endometriosis Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Endometriosis Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Endometriosis Treatment Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Endometriosis Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Endometriosis Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Endometriosis Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Endometriosis Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Endometriosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Endometriosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Debiopharm Group Company Information Table 72. Debiopharm Group Business Overview Table 73. Debiopharm Group Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Debiopharm Group Endometriosis Treatment Drugs Product Portfolio Table 75. Debiopharm Group Recent Development Table 76. Endoceutics, Inc Company Information Table 77. Endoceutics, Inc Business Overview Table 78. Endoceutics, Inc Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Endoceutics, Inc Endometriosis Treatment Drugs Product Portfolio Table 80. Endoceutics, Inc Recent Development Table 81. Mayne Pharma Group Company Information Table 82. Mayne Pharma Group Business Overview Table 83. Mayne Pharma Group Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Mayne Pharma Group Endometriosis Treatment Drugs Product Portfolio Table 85. Mayne Pharma Group Recent Development Table 86. Myovant Sciences Ltd Company Information Table 87. Myovant Sciences Ltd Business Overview Table 88. Myovant Sciences Ltd Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Myovant Sciences Ltd Endometriosis Treatment Drugs Product Portfolio Table 90. Myovant Sciences Ltd Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. AstraZeneca Endometriosis Treatment Drugs Product Portfolio Table 95. AstraZeneca Recent Development Table 96. AbbVie Inc Company Information Table 97. AbbVie Inc Business Overview Table 98. AbbVie Inc Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. AbbVie Inc Endometriosis Treatment Drugs Product Portfolio Table 100. AbbVie Inc Recent Development Table 101. Bayer AG Company Information Table 102. Bayer AG Business Overview Table 103. Bayer AG Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Bayer AG Endometriosis Treatment Drugs Product Portfolio Table 105. Bayer AG Recent Development Table 106. Pfizer Inc Company Information Table 107. Pfizer Inc Business Overview Table 108. Pfizer Inc Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Pfizer Inc Endometriosis Treatment Drugs Product Portfolio Table 110. Pfizer Inc Recent Development Table 111. Teva Pharmaceutical Industries Ltd Company Information Table 112. Teva Pharmaceutical Industries Ltd Business Overview Table 113. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Portfolio Table 115. Teva Pharmaceutical Industries Ltd Recent Development Table 116. Ipsen Pharma Company Information Table 117. Ipsen Pharma Business Overview Table 118. Ipsen Pharma Endometriosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Ipsen Pharma Endometriosis Treatment Drugs Product Portfolio Table 120. Ipsen Pharma Recent Development Table 121. North America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Endometriosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 123. North America Endometriosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 124. North America Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Endometriosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Endometriosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Endometriosis Treatment Drugs Market Share by Country (2021-2026) Table 129. North America Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Endometriosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Endometriosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 133. Europe Endometriosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Endometriosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Endometriosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Endometriosis Treatment Drugs Market Share by Country (2021-2026) Table 139. Europe Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Endometriosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Endometriosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Endometriosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Endometriosis Treatment Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Endometriosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Endometriosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 153. Latin America Endometriosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Endometriosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Endometriosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Endometriosis Treatment Drugs Market Share by Country (2021-2026) Table 159. Latin America Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Endometriosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Endometriosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Endometriosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Endometriosis Treatment Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Endometriosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Endometriosis Treatment Drugs Distributors List Table 174. Endometriosis Treatment Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Endometriosis Treatment Drugs Image Figure 2. Global Endometriosis Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endometriosis Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Endometriosis Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Oral Type Image Figure 6. Global Oral Type Sales YoY Growth (2021-2032) & (k units) Figure 7. Others Image Figure 8. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Endometriosis Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Endometriosis Treatment Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Endometriosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Endometriosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Endometriosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Endometriosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Endometriosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Endometriosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Endometriosis Treatment Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. E-Commerce Image Figure 26. Global E-Commerce Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Endometriosis Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Endometriosis Treatment Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Endometriosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Endometriosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Endometriosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Endometriosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Endometriosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Endometriosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Endometriosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Endometriosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Endometriosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Endometriosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Endometriosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Endometriosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Endometriosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Endometriosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Endometriosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Endometriosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Endometriosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Endometriosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Endometriosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Endometriosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Endometriosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Endometriosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Endometriosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Endometriosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Endometriosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Endometriosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Endometriosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Endometriosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Endometriosis Treatment Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Endometriosis Treatment Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • Others
Applications
  • Hospital Pharmacies
  • E-Commerce
  • Retail Pharmacies
  • Others
Companies covered
  • Debiopharm Group
  • Endoceutics, Inc
  • Mayne Pharma Group
  • Myovant Sciences Ltd
  • AstraZeneca
  • AbbVie Inc
  • Bayer AG
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • Ipsen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endometriosis Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endometriosis Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endometriosis Treatment Drugs Market by Type
  6. 1.3.1 Oral Type
  7. 1.3.2 Others
  8. 1.4 Global Endometriosis Treatment Drugs Market Size by Type
  9. 1.4.1 Global Endometriosis Treatment Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Endometriosis Treatment Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Endometriosis Treatment Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Endometriosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Endometriosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Endometriosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Endometriosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Endometriosis Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endometriosis Treatment Drugs Industry Trends
  2. 2.2 Endometriosis Treatment Drugs Industry Drivers
  3. 2.3 Endometriosis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Endometriosis Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endometriosis Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Endometriosis Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Endometriosis Treatment Drugs Price (2021-2026)
  4. 3.4 Global Endometriosis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endometriosis Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Endometriosis Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Endometriosis Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endometriosis Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endometriosis Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endometriosis Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Endometriosis Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Endometriosis Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endometriosis Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Endometriosis Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endometriosis Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endometriosis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endometriosis Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Endometriosis Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endometriosis Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endometriosis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endometriosis Treatment Drugs by Application
  1. 5.1 Endometriosis Treatment Drugs Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 E-Commerce
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Endometriosis Treatment Drugs Market Size by Application
  7. 5.2.1 Global Endometriosis Treatment Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Endometriosis Treatment Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Endometriosis Treatment Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Endometriosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Endometriosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Endometriosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Endometriosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Endometriosis Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Debiopharm Group
  2. 6.1.1 Debiopharm Group Company Information
  3. 6.1.2 Debiopharm Group Business Overview
  4. 6.1.3 Debiopharm Group Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Debiopharm Group Endometriosis Treatment Drugs Product Portfolio
  6. 6.1.5 Debiopharm Group Recent Developments
  7. 6.2 Endoceutics, Inc
  8. 6.2.1 Endoceutics, Inc Company Information
  9. 6.2.2 Endoceutics, Inc Business Overview
  10. 6.2.3 Endoceutics, Inc Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Endoceutics, Inc Endometriosis Treatment Drugs Product Portfolio
  12. 6.2.5 Endoceutics, Inc Recent Developments
  13. 6.3 Mayne Pharma Group
  14. 6.3.1 Mayne Pharma Group Company Information
  15. 6.3.2 Mayne Pharma Group Business Overview
  16. 6.3.3 Mayne Pharma Group Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mayne Pharma Group Endometriosis Treatment Drugs Product Portfolio
  18. 6.3.5 Mayne Pharma Group Recent Developments
  19. 6.4 Myovant Sciences Ltd
  20. 6.4.1 Myovant Sciences Ltd Company Information
  21. 6.4.2 Myovant Sciences Ltd Business Overview
  22. 6.4.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Myovant Sciences Ltd Endometriosis Treatment Drugs Product Portfolio
  24. 6.4.5 Myovant Sciences Ltd Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Endometriosis Treatment Drugs Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 AbbVie Inc
  32. 6.6.1 AbbVie Inc Company Information
  33. 6.6.2 AbbVie Inc Business Overview
  34. 6.6.3 AbbVie Inc Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Inc Endometriosis Treatment Drugs Product Portfolio
  36. 6.6.5 AbbVie Inc Recent Developments
  37. 6.7 Bayer AG
  38. 6.7.1 Bayer AG Company Information
  39. 6.7.2 Bayer AG Business Overview
  40. 6.7.3 Bayer AG Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer AG Endometriosis Treatment Drugs Product Portfolio
  42. 6.7.5 Bayer AG Recent Developments
  43. 6.8 Pfizer Inc
  44. 6.8.1 Pfizer Inc Company Information
  45. 6.8.2 Pfizer Inc Business Overview
  46. 6.8.3 Pfizer Inc Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Inc Endometriosis Treatment Drugs Product Portfolio
  48. 6.8.5 Pfizer Inc Recent Developments
  49. 6.9 Teva Pharmaceutical Industries Ltd
  50. 6.9.1 Teva Pharmaceutical Industries Ltd Company Information
  51. 6.9.2 Teva Pharmaceutical Industries Ltd Business Overview
  52. 6.9.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Industries Ltd Recent Developments
  55. 6.10 Ipsen Pharma
  56. 6.10.1 Ipsen Pharma Company Information
  57. 6.10.2 Ipsen Pharma Business Overview
  58. 6.10.3 Ipsen Pharma Endometriosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ipsen Pharma Endometriosis Treatment Drugs Product Portfolio
  60. 6.10.5 Ipsen Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Endometriosis Treatment Drugs Sales by Country
  2. 7.1.1 North America Endometriosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endometriosis Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endometriosis Treatment Drugs Market Size by Country
  6. 7.2.1 North America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endometriosis Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endometriosis Treatment Drugs Sales by Country
  2. 8.1.1 Europe Endometriosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endometriosis Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endometriosis Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endometriosis Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endometriosis Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Endometriosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endometriosis Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endometriosis Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endometriosis Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endometriosis Treatment Drugs Sales by Country
  2. 10.1.1 South America Endometriosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endometriosis Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endometriosis Treatment Drugs Market Size by Country
  6. 10.2.1 South America Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endometriosis Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endometriosis Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Endometriosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endometriosis Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endometriosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endometriosis Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Endometriosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endometriosis Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endometriosis Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endometriosis Treatment Drugs Value Chain Analysis
  2. 12.1.1 Endometriosis Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endometriosis Treatment Drugs Production Mode & Process
  7. 12.2 Endometriosis Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endometriosis Treatment Drugs Distributors
  10. 12.2.3 Endometriosis Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst